| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -3.36% | +0.11% | -3.46% | -3.46% | — |
| 14d | 1 | +100.00% | -8.94% | +0.56% | -9.49% | -9.49% | — |
| 30d | 1 | +100.00% | -18.75% | +3.63% | -22.38% | -22.38% | — |
| 60d | 1 | +100.00% | -32.05% | +5.20% | -37.25% | -37.25% | — |
| 90d | 1 | +100.00% | -20.51% | +7.42% | -27.93% | -27.93% | — |
| 180d | 1 | +100.00% | -43.37% | +9.52% | -52.89% | -52.89% | — |
| 1y | 1 | +100.00% | -64.81% | -3.54% | -61.27% | -61.27% | — |
| 2y | 1 | +100.00% | -70.26% | +5.05% | -75.31% | -75.31% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| ABCL ABCELLERA BIOLOGICS INC. | PURCHASE Chief Technology Officer | 875,000 | $16.89 | $14.78M | 875,000 | Sep 1, 2021 | Sep 3, 2021 ↗ |
| ABCL ABCELLERA BIOLOGICS INC. | SALE Chief Technology Officer | 875,000 | — | — | 875,000 | Sep 1, 2021 | Sep 3, 2021 ↗ |
| ABCL ABCELLERA BIOLOGICS INC. | SALE Chief Technology Officer | 1,000,000 | $25.50 | $25.50M | 0 | Jun 9, 2021 | Jun 10, 2021 ↗ |
| ABCL ABCELLERA BIOLOGICS INC. | PURCHASE Chief Technology Officer | 1,000,000 | $0.03 | $34.3K | 1,000,000 | Mar 19, 2021 | Apr 23, 2021 ↗ |
| ABCL ABCELLERA BIOLOGICS INC. | SALE Chief Technology Officer | 1,000,000 | — | — | 0 | Mar 19, 2021 | Apr 23, 2021 ↗ |